Loncar China BioPharma ETF: Last Quarter Change, Reduced
No data for this tab of Loncar China BioPharma ETF on this site yet.
Similar ETFs
| ETF Name | Country | Net Assets | Overlap |
|---|---|---|---|
| Tema Oncology ETF (CANC) | United States | $0.160B | 5.14% |
| Virtus Biotech Etf (BBP) | United States | $0.059B | 4.59% |
| Range Cancer Therapeutics ETF (CNCR) | 3.67% | ||
| Defiance Nasdaq Junior Biotechnology ETF (IBBJ) | 3.44% | ||
| Harbor Health Care ETF (MEDI) | United States | $0.028B | 3.07% |
| Goldman Sachs Human Evolution ETF (GDNA) | 2.88% | ||
| VanEck Biotech ETF (BBH) | United States | $0.372B | 2.53% |
| First Trust NYSE Arca Biotechnology Index Fund (FBT) | United States | $2.270B | 2.53% |
| Fidelity Disruptive Medicine ETF (FMED) | United States | $0.061B | 2.50% |
| iShares Biotechnology ETF (IBB) | United States | $8.123B | 2.31% |